Novel nanotech improves cystic fibrosis antibiotic by 100,000-fold, research shows

New nanotechnology could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.